📑Pandemic influenza vaccine.
Procurement process summary
This process is to purchase Pandemic influenza vaccine.
This contract was awarded by 🇪🇺 The Ministry of Health and Care Services for an amount of NOK 463,000,000 to 1 supplier. It was published on 2013-07-09 through open
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇪🇺 The Ministry of Health and Care Services Buying unitnot reported Publication date2013-07-09 Contest statusnot reported DescriptionThe Norwegian Institute of Public Health (NIPH), on behalf of the Norwegian Ministry of Health and Care Services, will conduct a competitive dialogue for procurement of pandemic influenza vaccine to the Norwegian population. The purpose of this tender is to ensure that the inhabitants of Norway have access to vaccine in case of a possible pandemic influenza throughout the agreement period. The awarded contracts will contain an option for delivery of pandemic influenza vaccine in the agreement period. The viral component must be in accordance with the recommendations made by the WHO. The total volume will cover full immunization of up to 5-5 500 000 people (the Norwegian population at the time of delivery). The number of doses ordered by the NIPH from each supplier in case of an outbreak will be dependent on the chosen immunization regime and the expected severity of the pandemic. NIPH's preliminary intention is to enter into agreements with two suppliers in order to ensure the best possible security of supply. In addition to the primary obligation comprising manufacturing and supply of the vaccines, and subject to separate remuneration, both suppliers shall reserve production capacity adequate to fulfil their delivery obligations under the agreements. In order to establish a complete set of terms and conditions for the competition and the delivery agreements in accordance with what the market operators are able to meet, NIPH is dependent on further information from potential suppliers. NIPH is i.e. dependent on further information regarding possible delivery time, doses and packaging. Considering that NIPH is currently not able to establish a complete set of tender documents, the procurement will be conducted as a competitive dialogue. By documenting the fulfilment of the qualification criteria in the current invitation, suppliers will be qualified and invited to further participation in the dialogue. Note: To register your interest in this notice and obtain any additional information please visit the Doffin Web Site at: http://www.doffin.no/Search/Search_Switch.aspx?ID=299620.Awards
This award was granted to GlaxoSmithKline AS by The Ministry of Health and Care Services for an amount of NOK 463,000,000. The procurement process was conducted through open for the category of goods. The award was granted on 2014-03-07. This is award number 1.
| Supplier | Amount | Award date | Award number |
|---|---|---|---|
| 🇳🇴 GlaxoSmithKline AS | NOK 463,000,000 | 2014-03-07 | 1 |
Market context and opportunities
The execution of this contract allows the entity The Ministry of Health and Care Services to fulfill its public service objectives efficiently.
The open purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberEU_ocds-70d2nz-656d133f-8cc9-4349-983d-39d3ff028c33-award-1Publication date2013-07-09Contract datenot reportedAward date2014-03-07CategoriesgoodsPurchase modalityopenMethod detailspt_competitive_dialogueStatusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
